Suspected pharmacokinetic interaction between raltegravir and the 3D regimen of ombitasvir, dasabuvir and paritaprevir/ritonavir in an HIV-HCV liver transplant recipient
Crossref DOI link: https://doi.org/10.1007/s00228-015-1936-6
Published Online: 2015-09-12
Published Print: 2016-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Cattaneo, Dario
Sollima, Salvatore
Charbe, Nitin
Resnati, Chiara
Clementi, Emilio
Gervasoni, Cristina
Text and Data Mining valid from 2015-09-12